Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

NeuroOne Reports Fiscal Q4 Revenue Up 38.4% to $3.8 Million, Record $4.5 Million Order

Positive Impact 4 of 5 earnings Written later

NeuroOne preliminarily reported fiscal fourth-quarter 2026 product revenue of approximately $3.8 million, up 38.4% from the prior-year quarter, and full-year revenue of approximately $10.5 million, up 15.6% and at the top of its guidance range. The company also disclosed a $4.5 million purchase order received in September 2026, which it describes as its largest ever, and open purchase orders of $5.4 million as of September 30, 2026. The figures are unaudited and subject to change, with final results due in December 2026.

Key points

  • Fiscal Q4 2026 product revenue of approximately $3.8 million, up 38.4% from approximately $2.7 million in Q4 2025.
  • Full-year fiscal 2026 revenue of approximately $10.5 million, up 15.6%, at the top of the previously announced $9.2 million to $10.5 million guidance range.
  • $4.5 million purchase order received in September 2026; about $1.0 million shipped by September 30, with the remaining $3.6 million expected to begin shipping in fiscal Q1 2027.
  • Open purchase orders totaled $5.4 million as of September 30, 2026; complete results are expected in December 2026 with the Form 10-K.

The filing

CompanyNEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
Form8-K, current report
Filed with the SECOct 5, 2026, 9:20 AM ET
Accession number0001213900-26-106677

Items reported: 2.02 Results of Operations8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.